Breast cancer
Results
Phase 3
This study was looking at adding the drug sunitinib to docetaxel as treatment for breast cancer that had come back or spread to another part of the body (advanced breast cancer). The women taking part had breast cancer that was .
Recruitment start: 4 June 2007
Recruitment end: 30 October 2008
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Peter Simmonds
National Institute for Health Research Cancer Research Network (NCRN)
Pfizer
Last reviewed: 30 Nov 2012
CRUK internal database number: 3009
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
